IP Library › Assignment 068782/0512
Patent Assignment
Reel/Frame 068782/0512

Merger

Recorded: 2024-10-03 Pages: 5
Assignor
CTI BIOPHARMA CORP.
Executed: 2024-09-30
Assignee
SOBI, INC.
77 4TH AVENUE, 3RD FLOOR, WALTHAM, MASSACHUSETTS, 02451
Covered Properties (14)
Oxygen Linked Pyrimidine Derivatives
Patent: 8,153,632 →
Application: 12/093,867 →
Publication: US 2009/0075999
11-(2-Pyrrolidin-1-Yl-Ethoxy)-14,19-Dioxa-5,7,26-Triaza-Tetracyclo[19.3.1.1(2,6).1(8,12)]Heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-Decaene Maleate Salt
Patent: 8,987,243 →
Application: 13/133,288 →
Publication: US 2011/0263616
11-(2-Pyrrolidin-1-Yl-Ethoxy)-14,19-Dioxa-5,7,26-Triaza-Tetracyclo[19.3.1.1(2,6).1(8,12)]Heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-Decaene Citrate Salt
Patent: 8,980,873 →
Application: 13/133,297 →
Publication: US 2011/0294831
(9E)-15-(2-Pyrrolidin-1-Yl-Ethoxy)-7,12,25-Trioxa-19,21,24-Triaza-Tetracyclo[18.3.1.1(2.5).1(14,18)]Hexacosa-1(24),2,4,9,14,16,18(26),20,22-Nonaene Citrate Salt
Patent: 9,062,074 →
Application: 13/384,139 →
Publication: US 2012/0196876
Oxygen Linked Pyrimidine Derivatives
Patent: 8,415,338 →
Application: 13/438,989 →
Publication: US 2012/0196855
Oxygen Linked Pyrimidine Derivatives
Patent: 9,573,964 →
Application: 13/771,546 →
Publication: US 2013/0172338
11-(2-Pyrrolidin-1-Yl-Ethoxy)-14,19-Dioxa-5,7,26-Triaza-Tetracyclo[19.3.1.1(2,6).1(8,12)]Heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-Decaene Citrate Salt
Patent: 9,624,242 →
Application: 14/621,726 →
Publication: US 2015/0322084
Oxygen Linked Pyrimidine Derivatives
Application: 15/398,851 →
Publication: US 2017/0112846
Oxygen Linked Pyrimidine Derivatives
Application: 16/677,080 →
Publication: US 2020/0071339
Methods of Treating Transplant Rejection
Application: 17/099,664 →
Publication: US 2021/0069199
Oxygen Linked Pyrimidine Derivatives
Application: 17/465,541 →
Publication: US 2022/0241291
Oxygen Linked Pyrimidine Derivatives
Application: 17/902,539 →
Methods of Treating FLT3-Mutated Hematologic Cancers
Application: 18/630,424 →
Methods of Treating Vexas
Application: 63/670,409 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 21, 2008
From: BLANCHARD, STEPHANIE; LEE, CHENG HSIA ANGELINE; NAGARAJ, HARISH KUMAR MYSORE; POULSEN, ANDERS
To: S*BIO PTE LTD
Reel/Frame 021715/0049 →
Assignment of Assignor's Interest Jul 1, 2011
From: DYMOCK, BRIAN; LEE, CHENG H.; WILLIAM, ANTHONY D.
To: S*BIO PTE LTD.
Reel/Frame 026536/0958 →
Assignment of Assignor's Interest Aug 22, 2011
From: DYMOCK, BRIAN; LEE, CHENG H.; WILLIAM, ANTHONY D.
To: S*BIO PTE LTD.
Reel/Frame 026784/0140 →
Assignment of Assignor's Interest Apr 9, 2012
From: DYMOCK, BRIAN; LEE, CHENG H.; WILLIAM, ANTHONY D.
To: S*BIO PTE LTD.
Reel/Frame 028016/0542 →
Assignment of Assignor's Interest Aug 22, 2012
From: S*BIO PTE LTD.
To: CELL THERAPEUTICS, INC.
Reel/Frame 028825/0591 →
Assignment of Assignor's Interest Aug 22, 2012
From: S*BIO PTE LTD.
To: CELL THERAPEUTICS, INC.
Reel/Frame 028825/0685 →
Assignment of Assignor's Interest Aug 22, 2012
From: S*BIO PTE LTD.
To: CELL THERAPEUTICS, INC.
Reel/Frame 028825/0651 →
Assignment of Assignor's Interest Aug 22, 2012
From: S*BIO PTE LTD.
To: CELL THERAPEUTICS, INC.
Reel/Frame 028825/0612 →
Assignment of Assignor's Interest Aug 22, 2012
From: S*BIO PTE LTD.
To: CELL THERAPEUTICS, INC.
Reel/Frame 028825/0706 →
Change of Name Jul 29, 2014
From: CELL THERAPEUTICS, INC.
To: CTI BIOPHARMA CORP.
Reel/Frame 033430/0516 →
Assignment of Assignor's Interest Apr 19, 2022
From: BLANCHARD, STEPHANIE; LEE, CHENG HSIA ANGELINE; NAGARAJ, HARISH KUMAR MYSORE; POULSEN, ANDERS
To: S*BIO PTE LTD.
Reel/Frame 059638/0463 →
Assignment of Assignor's Interest Apr 19, 2022
From: S*BIO PTE LTD.
To: CELL THERAPEUTICS, INC.
Reel/Frame 059638/0471 →
Assignment of Assignor's Interest May 5, 2022
From: BETTS, BRIAN C.; YU, XUEZHONG; ANASETTI, CLAUDIO
To: CTI BIOPHARMA CORP.
Reel/Frame 059830/0974 →
Assignment of Assignor's Interest Sep 28, 2022
From: S*BIO PTE LTD.
To: CELL THERAPEUTICS, INC.
Reel/Frame 061245/0934 →
Assignment of Assignor's Interest Sep 28, 2022
From: BLANCHARD, STEPHANIE; LEE, CHENG HSIA ANGELINE; NAGARAJ, HARISH KUMAR MYSORE; POULSEN, ANDERS
To: S*BIO PTE LTD.
Reel/Frame 061244/0195 →
Assignment of Assignor's Interest Sep 28, 2022
From: S*BIO PTE LTD.
To: CELL THERAPEUTICS, INC.
Reel/Frame 061244/0203 →
Assignment of Assignor's Interest Sep 28, 2022
From: BLANCHARD, STEPHANIE; LEE, CHENG HSIA ANGELINE; NAGARAJ, HARISH KUMAR MYSORE; POULSEN, ANDERS
To: S*BIO PTE LTD.
Reel/Frame 061244/0723 →
Assignment of Assignor's Interest Sep 28, 2022
From: S*BIO PTE LTD.
To: CELL THERAPEUTICS, INC.
Reel/Frame 061244/0838 →
Assignment of Assignor's Interest Sep 28, 2022
From: BLANCHARD, STEPHANIE; LEE, CHENG HSIA ANGELINE; NAGARAJ, HARISH KUMAR MYSORE; POULSEN, ANDERS
To: S*BIO PTE LTD.
Reel/Frame 061245/0916 →
Change of Name Sep 28, 2022
From: CELL THERAPEUTICS, INC.
To: CTI BIOPHARMA CORP.
Reel/Frame 061561/0650 →
Change of Name Sep 28, 2022
From: CELL THERAPEUTICS, INC.
To: CTI BIOPHARMA CORP.
Reel/Frame 061561/0842 →
Change of Name Sep 28, 2022
From: CELL THERAPEUTICS, INC.
To: CTI BIOPHARMA CORP.
Reel/Frame 061568/0976 →
Assignment of Assignor's Interest Nov 4, 2022
From: S*BIO PTE LTD.
To: CELL THERAPEUTICS, INC.
Reel/Frame 061661/0708 →
Change of Name Nov 4, 2022
From: CELL THERAPEUTICS, INC.
To: CTI BIOPHARMA CORP.
Reel/Frame 061884/0407 →
Assignment of Assignor's Interest Nov 4, 2022
From: BLANCHARD, STEPHANIE; LEE, CHENG HSIA ANGELINE; NAGARAJ, HARISH KUMAR MYSORE; SUN, ERIC T.
To: S*BIO PTE LTD.
Reel/Frame 061661/0700 →